Literature DB >> 19825046

The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors.

Anjali P Mascarenhas1, Karin Musier-Forsyth.   

Abstract

HIV-1 is a retrovirus that causes AIDS in humans. The RNA genome of the virus encodes a Gag polyprotein, which is further processed into matrix, capsid and nucleocapsid proteins. These proteins play a significant role at several steps in the viral life cycle. In addition, various stages of assembly, infection and replication of the virus involve necessary interactions with a large number of supplementary proteins/cofactors within the infected host cell. This minireview focuses on the proteomics of the capsid protein, its influence on the packaging of nonviral molecules into HIV-1 virions and the subsequent role of the molecules themselves. These interactions and their characterization present novel frontiers for the design and advancement of antiviral therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825046     DOI: 10.1111/j.1742-4658.2009.07315.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  19 in total

1.  Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.

Authors:  Katrina J Heyrana; Boon Chong Goh; Juan R Perilla; Tam-Linh N Nguyen; Matthew R England; Maria C Bewley; Klaus Schulten; Rebecca C Craven
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaoxia Wang; Andrew J Mouland; Sudhanshu Shekhar; Xi Yang; Xiaojian Yao
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

3.  Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.

Authors:  Christopher P Jones; Siddhartha A K Datta; Alan Rein; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Structure of a monomeric mutant of the HIV-1 capsid protein.

Authors:  Ronald Shin; Ywh-Min Tzou; N Rama Krishna
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

5.  Cyclophilin A-dependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines.

Authors:  Taichiro Takemura; Miyako Kawamata; Miho Urabe; Tsutomu Murakami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1.

Authors:  Varun Dewan; Min Wei; Lawrence Kleiman; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

7.  Proteomic analysis of HIV-T cell interaction: an update.

Authors:  Gertjan Kramer; Perry D Moerland; Rienk E Jeeninga; Wytze J Vlietstra; Jeffrey H Ringrose; Carsten Byrman; Ben Berkhout; Dave Speijer
Journal:  Front Microbiol       Date:  2012-07-04       Impact factor: 5.640

8.  HIV capsid is a tractable target for small molecule therapeutic intervention.

Authors:  Wade S Blair; Chris Pickford; Stephen L Irving; David G Brown; Marie Anderson; Richard Bazin; Joan Cao; Giuseppe Ciaramella; Jason Isaacson; Lynn Jackson; Rachael Hunt; Anne Kjerrstrom; James A Nieman; Amy K Patick; Manos Perros; Andrew D Scott; Kevin Whitby; Hua Wu; Scott L Butler
Journal:  PLoS Pathog       Date:  2010-12-09       Impact factor: 6.823

9.  Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.

Authors:  Rebeca Bocanegra; María Nevot; Rosa Doménech; Inmaculada López; Olga Abián; Alicia Rodríguez-Huete; Claudio N Cavasotto; Adrián Velázquez-Campoy; Javier Gómez; Miguel Ángel Martínez; José Luis Neira; Mauricio G Mateu
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  Functional constraints on HIV-1 capsid: their impacts on the viral immune escape potency.

Authors:  Taichiro Takemura; Tsutomu Murakami
Journal:  Front Microbiol       Date:  2012-10-17       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.